Current options for the treatment of facial angiofibromas.

Salido-Vallejo, R; Garnacho-Saucedo, G; Moreno-Giménez, J C

Salido-Vallejo, R; Garnacho-Saucedo, G; Moreno-Giménez, J C.

Affiliation

Salido-Vallejo R; Servicio de Dermatología, Hospital Universitario Reina Sofía, Córdoba, España. Electronic address: rsalidovallejo@aedv.es.
Garnacho-Saucedo G; Servicio de Dermatología, Hospital Universitario Reina Sofía, Córdoba, España.
Moreno-Giménez JC; Servicio de Dermatología, Hospital Universitario Reina Sofía, Córdoba, España.

Actas Dermosifiliogr ; 105(6): 558-68, 2014.

Article in En, Es | MEDLINE | ID: mdl-23522741

Subject(s)

Angiofibroma/therapy; Facial Neoplasms/therapy; Skin Neoplasms/therapy; Algorithms; Antibiotics, Antineoplastic/therapeutic use; Humans; Sirolimus/therapeutic use

Key words

Angiofibroma; Esclerosis tuberosa; Laser therapy; Sirolimus; Terapia láser; Terapéutica; Therapeutics; Tuberous sclerosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Facial Neoplasms / Angiofibroma Type of study: Guideline Limits: Humans Language: En / Es Journal: Actas Dermosifiliogr Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google